Inception Mining Inc. Announces Additional Drill Program Data
Jan 09, 2017 13:50 pm UTC| Business
SALT LAKE CITY, Jan. 09, 2017 -- Inception Mining Inc. is pleased to report the twelfth drill hole in the CMCS drill program (“CMCS-12”), completed at the recently-acquired property adjacent to the Clavo Rico mine site,...
Jan 09, 2017 13:45 pm UTC| Business
BEDFORD, Mass., Jan. 09, 2017 -- ConforMIS Inc. (NASDAQ:CFMS), a medical technology company that develops, manufactures and sells joint replacement implants that are customized to fit each patient's unique anatomy,...
Acuity Brands Reports Record First Quarter Results
Jan 09, 2017 13:31 pm UTC| Business
ATLANTA, Jan. 09, 2017 -- Acuity Brands, Inc. (NYSE:AYI) (“Company”) today announced record first quarter net sales, net income, and diluted earnings per share (“EPS”). Fiscal 2017 first quarter net sales of $851.2...
EyeGate Receives Additional Milestone Payment from Valeant Pharmaceuticals for EGP-437
Jan 09, 2017 13:30 pm UTC| Business
WALTHAM, Mass., Jan. 09, 2017 -- EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) (“EyeGate” or the “Company”), a specialty pharmaceutical company that focuses on developing and commercializing products for treating diseases...
Signal Genetics Sets Date for Special Meeting of Stockholders
Jan 09, 2017 13:30 pm UTC| Business
CARLSBAD, Calif., Jan. 09, 2017 -- Signal Genetics, Inc. (NASDAQ:SGNL) announced today it has set a date for a special meeting of its stockholders to vote on matters related to the proposed merger with Miragen...
Evoke Pharma to Attend 2017 JPMorgan Healthcare Conference
Jan 09, 2017 13:30 pm UTC| Business
SOLANA BEACH, Calif., Jan. 09, 2017 -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that its President and Chief...
Jan 09, 2017 13:30 pm UTC| Business
SAN RAMON, Calif., Jan. 09, 2017 -- SteadyMed Therapeutics Ltd. (NASDAQ:STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and high-value diseases with unmet...